PD-L1 antibody (C-Term) (FITC)
-
- Target See all PD-L1 Antibodies
- PD-L1 (CD274 (PD-L1))
-
Binding Specificity
- AA 261-209, C-Term
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This PD-L1 antibody is conjugated to FITC
-
Application
- Western Blotting (WB), ELISA
- Cross-Reactivity
- Human
- Cross-Reactivity (Details)
- Calculated cross reactivity: Hu
- Characteristics
- CD274, CT (CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1, Programmed cell death 1 ligand 1, B7 homolog 1, CD274) (FITC)
- Purification
- Purified by Protein A affinity chromatography.
- Immunogen
- KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 261-209 in the C-terminal region of human CD274, UniProt Accession #Q9NZQ7.
- Isotype
- IgG
- Top Product
- Discover our top product PD-L1 Primary Antibody
-
-
- Application Notes
- Optimal working conditions should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in PBS, pH 7.2.
- Storage
- -20 °C
- Storage Comment
- -20°C
-
- Target
- PD-L1 (CD274 (PD-L1))
- Alternative Name
- CD274 (PD-L1 Products)
- Synonyms
- B7-H antibody, B7H1 antibody, PD-L1 antibody, PDCD1L1 antibody, PDCD1LG1 antibody, PDL1 antibody, A530045L16Rik antibody, B7h1 antibody, Pdcd1l1 antibody, Pdcd1lg1 antibody, Pdl1 antibody, RGD1566211 antibody, CD274 molecule antibody, CD274 antigen antibody, programmed cell death 1 ligand 2 antibody, CD274 antibody, Cd274 antibody, PDCD1LG2 antibody
- NCBI Accession
- NP_054862
- UniProt
- Q9NZQ7
- Pathways
- Cancer Immune Checkpoints
-